Artículo
Novartis delivers 4.7 million treatments of anti-malarial medicine to Tanzania on Africa Malaria Day
Novartis has delivered 4.7 million treatments of its life-saving anti-malaria medicine, Coartem, to the United Republic of Tanzania, an African country where malaria is the leading cause of death in both children and adults. This delivery is part of a larger global effort to provide access to Coartem without profit to patients living in malaria-endemic countries...The company urges governments, companies and other organizations to work together to broaden access and remove cultural or educational hindrances to treatment...